Register Login

ARDELYX, INC. (ARDX)

SymbolARDX
NameARDELYX, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address400 FIFTH AVENUE,SUITE 210, WALTHAM, Massachusetts, 02451, United States
Telephone+1 510 745-1700
Fax—
Email—
Websitehttps://www.ardelyx.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001437402
Description

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Additional info from NASDAQ:
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

2026-08-17 20:05

(99% Neutral) ARDELYX, INC. (ARDX) Announces Update on Collaboration with IRS Employer Identification Number

Read more
2026-08-17 14:09

ARDX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Ardelyx (ARDX)

Read more
2026-08-14 14:07

ARDX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ardelyx

Read more
2026-08-14 02:44

Ardelyx Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ardelyx (ARDX)

Read more
2026-08-11 19:11

New Form SCHEDULE 13G/A - ARDELYX, INC. <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001104659-26-094212 <b>Size:</b> 18 KB

Read more
2026-08-10 17:04

New Form S-8 - ARDELYX, INC. <b>Filed:</b> 2026-08-10 <b>AccNo:</b> 0001437402-26-000049 <b>Size:</b> 448 KB

Read more
2026-07-23 12:01

Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026

Read more
2026-07-17 20:09

Director RAAB MICHAEL 🟡 adjusted position in 41.7K shares (1 derivative) of ARDELYX, INC. (ARDX) at $5.06 Transaction Date: Jul 15, 2026 | Filing ID: 000016

Read more
2026-07-02 21:00

(99% Neutral) ARDELYX, INC. (ARDX) Announces Business Combination

Read more
2026-06-22 20:01

Williams Laura A 🟡 adjusted position in 81.9K shares (1 derivative) of ARDELYX, INC. (ARDX) at $5.99 Transaction Date: Jun 18, 2026 | Filing ID: 000008

Read more